Order Entry
United States
ContactUsLinkComponent
Lipoxin A4 ELISA Kit, Eagle Biosciences
Lipoxin A4 ELISA Kit, Eagle Biosciences
Catalog # 102994-744
Supplier:  Eagle Biosciences
CAS Number:  
Lipoxin A4 ELISA Kit, Eagle Biosciences
Catalog # 102994-744
Supplier:  Eagle Biosciences
Supplier Number:  LA439-K01
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Host:
  • Primary antibody reactivity:
  • Description:
    Lipoxin A4 ELISA Kit
  • Size:
    1 kit
  • Environmentally Preferable:
  • Cat. No.:
    102994-744
  • Supplier no.:
    LA439-K01

Specifications

About this item

Lipoxin A4 ELISA is to detect Lipoxin A4 in biological fluids by a microplate enzyme immuno.

  • Dynamic Range: 0.02 - 2.0 ng/mL
  • Sensitivity: 0.02 ng/mL
  • Incubation: 2 hours

Lipoxin A4 (LXA4) is a biologically active lipoxygenase interaction product derived from arachidonic acid. Arachidonic acid is first oxygenated by 15-lipoxygenase to form 15-HETE which is converted by 5-lipoxygenase and epoxide hydrase to generate LXA4. LXA4 stimulates leukocyte chemotaxis without aggregation and inhibits natural killer cell cytotoxicity. It also provokes contraction of parenchymal strips and stimulates microvascular changes. Recent findings indicate that LXA4 inhibits leukocyte-dependent inflammation. Determination of LXA4 level may provide new understanding of the role of LXA4 in basic cellular reactions and in pathophysiology of inflammation and other disease processes.